Latest filing published 07 Oct 2013 for Maidenform Brands, Inc..
No signal scores available.
This profile gathers the share dealings of Nanci Prado across 2 companies, led by Maidenform Brands, Inc. and Omrix Biopharmaceuticals, Inc. We count 30 filings; the first trade dates from 8 November 2007 and the latest from 7 October 2013.
The open-market record consists of 4 sales worth €258k, with no purchase. The rest of the record consists of 20 share grants and 3 option exercises.
Most recently, on 7 October 2013, the filings show a transaction in Maidenform Brands, Inc. Typically, a trade is published a median of 3 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 30 declarations